SEC Form 4 · accession 0001628280-26-056061
Organon & Co. · OGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ferreira Juan Camilo Arjona
Officer — Head of R&D & CMO
Period of report
Aug 11, 2026
Accepted (ET)
Aug 12, 2026 · 1:01 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001821825
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 11, 2026 | M | 11,519 | $0.00 | A | 41,566 | D | |
| Common Stock | Aug 11, 2026 | F | 4,134 | $13.62 | D | 37,432 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | Aug 11, 2026 | M | 11,519 | A | — | — | Common Stock | 11,519 | 0 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of Organon & Co. ("Organon") common stock.
- F2These restricted stock units vest and are distributed as shares of Organon common stock in three equal installments with the third and final vesting occurring on August 11, 2026.